Joint Talk - Deciphering the Cell with GE Healthcare Cell Technologies / The Importance of High Content Analysis for Stem Cell Culture, Differentiation and Media Development
Conference Recording Jan 29, 2013
About the SpeakerDr. Bergendahl is a trained chemist/biochemist and received his PhD in Biology 2003 from the Phillips University in Marburg, Germany. In 2009 he joined Roche Pharma to work on therapeutic antibodies, before he was recruited by Miltenyi Biotec GmbH in Germany to set up a new department for cell culture technology. He is focused on stem cell culture, directed differentiation, automation and cell-based screening. He is responsible for the development of new specialty culture media (including GMP-compliant products) intended for research and clinical applications. Dr. Bergendahl holds several patents for applications in biochemistry and stem cell biology.
The talk covers the development of specialty media for translational research in the field of hematopoietic stem cells. We describe how we have developed and used a high-content screen platform via integrated HCR and FACS into commercial liquid handler platforms.Dr. Bergendahl shares his talk with Peter Zehetmayer, Sales Specialist Cell Technologies, GE Healthcare.